Head-to-head · WeighScore
Boston Medical Group vs Vitara RX
By GLP-1 ScorecardUpdated
Score comparison
Vitara RX has the higher recorded score — 86/100 to 61.9/100.
Vitara RX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Compounded GLP-1 marketplace with conflicting advertised prices and unresolved shipping-policy details.
Before you choose
Boston Medical Group does not publish a semaglutide price, so its Boston Medical Group review sets out what it does disclose, while the Vitara RX review explains the conditions attached to Vitara RX's figure. The semaglutide cost page compares published rates across the field. Ask Boston Medical Group for a written total before treating either one as the cheaper choice.
If neither one fits, Boston Medical Group vs Breeze Meds and CaliberRx vs Vitara RX compare each of them with another graded program, and the list of alternatives to Boston Medical Group ranks the programs closest to Boston Medical Group on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the Collective review covers one graded close to these two, at 71.6/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Boston Medical Group | Vitara RX |
|---|---|---|
| WeighScore | 61.9/100 | 86/100 |
| Grade | C | B |
| Site position | #302 | #10 |
| Semaglutide | Not disclosed for the selected prescription | Advertised from $99/month with an annual plan and discount code ($279 reference); conflicting displays—confirm selected charge. |
| Tirzepatide | Not disclosed | Advertised from $198/month with an annual plan and discount code ($389 reference); conflicting displays—confirm selected charge. |
| Coverage | Confirm eligibility for the selected program | Site lists 49 states, Alaska omitted; confirm medication-specific availability |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Strengths
- Costs page publishes a 12-week total including a telemedicine platform fee
- Program page advertises an initial consultation
What to consider
- The starting monthly figure excludes the platform fee
- The public pages do not establish separate tirzepatide pricing or a selected payment schedule
- The public terms do not settle the refund after stopping treatment early
Strengths
- Named compounded semaglutide and tirzepatide offerings
- Ongoing provider messaging advertised
- Terms allow directing prescriptions to another pharmacy
What to consider
- Prices changed with a November site rebuild; annual-plan and discount-code conditions need confirming
- FAQ, terms and returns pages cited earlier no longer load
- Published list omitted Alaska
- Refrigeration instructions conflict with the returns policy
- No universal lab schedule or testing price established
- Website policy descriptions leave clinical and dispensing roles unclear
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.